Please assess the completion status of the following clinical trial:

Trial Title: Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled Syringe

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~* Moderately to severely active Rheumatoid arthritis (RA) for at least 6 months, which is not adequately controlled by non-biologics DMARDs.~* No contraindications to anti-Tumor necrosis factor (TNF) agents.~* Either biologics naive or biologics-experienced but with no experience of self-administration medication using autoinjector or pen.~* Patients must be able and willing to self-inject BI 695501. Further inclusion criteria apply.~Exclusion criteria:~* Experience with self-administration of medication using an autoinjector or pen.~* American College of Rheumatology functional Class IV or wheelchair/ bed bound.~* Primary or secondary immunodeficiency.~* History of tuberculosis (TB). Further exclusion criteria apply.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- BI 695501 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).